![](/img/cover-not-exists.png)
Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)
Miguel A. Sanz, Louis Aledort, Susan D. Mathias, Xuena Wang, John J. IsittVolume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2010.10.017
File:
PDF, 401 KB
english, 2011